Category: Blog
-
What Does It Mean By FDA Accelerated Approval Of Cancer Drugs?
A new cancer drug can reach patients before its expected benefit has been fully verified. Here is what FDA accelerated approval means, why confirmatory trials matter, and what patients can ask.
-
What Being a PhD Student Has Taught Me About Patience
A personal reflection on how PhD training turns waiting, failed experiments, and repeated troubleshooting into patience.
-
Can weight-loss drugs lower cancer risk? What the GLP-1 boom is really telling us
Written and edited by Abel B. Daartey, PharmD Key Takeaways GLP-1 drugs may lower cancer risk indirectly by helping some people lose substantial weight and improve metabolic health. The evidence for cancer is promising, but much of it is observational, so it cannot yet prove that GLP-1 medicines prevent cancer. These medicines should be used…
-
My First Day in the Lab: Confusion, Curiosity, and Silent Panic
series by Abel B. Daartey Starting a PhD can feel exciting on the outside, but deeply uncertain on the inside. My first day in the lab reminded me that admission into a programme is not the same thing as feeling prepared for it. This is a story about confusion, quiet fear, and the slow process…
-
Why Are More Young People Getting Colon Cancer?
Early-onset colorectal cancer is rising in adults younger than 50. The causes are probably mixed: diet, metabolism, gut bacteria, alcohol, sedentary life, early-life exposures, and delayed recognition of symptoms.
